Company PlaceholderNational GraphiteNGRC info
$0.03info0.00%24h
Global rank5591
Market cap$4.94M
Change 7d-8.57%
YTD Performance-38.46%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Financial Services
Business data

    National Graphite (NGRC) Stock Overview

    National Graphite Corp., through its subsidiary, Biotech Development Corp., operates as a biopharmaceutical risk/cost-sharing company. The company collaborates with clinical stage companies that develop new biological entities or new therapeutically platforms for the treatment of various diseases, rare diseases, and diseases with unmet needs. It is developing a drug candidate called ELAFIN, which is a human identic protein for the treatment of postoperative inflammatory complications. National Graphite Corp. has a collaboration agreement with Proteo Inc. for developing ELAFIN. The company was formerly known as Lucky Boy Silver Corporation and changed its name to National Graphite Corp. in May 2012. National Graphite Corp. was founded in 2006 and is based in Duesseldorf, Germany.

    NGRC Stock Information

    Symbol
    NGRC
    Address
    Linienstrasse 75Duesseldorf, 40237Germany
    Founded
    -
    Trading hours
    -
    Website
    Country
    🇩🇪 Germany
    Phone Number
    49 172 6544175

    National Graphite (NGRC) Price Chart

    -
    Value:-

    National Graphite Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $0.032000002
    N/A
    Market Cap
    $4.94M
    N/A
    Shares Outstanding
    154.31M
    N/A
    Employees
    0
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    © 2024 Topstocks.org